Clinical Trials in Houston

Showing 8501-8520 of 17,885 trials

Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years

NCT01676402

This is a Phase Ib study in healthy adults (18-70 years) to evaluate the safety, tolerability, and immunogenicity of same season and sequential season vaccination schedules consisting of the 2012/2013 seasonal influenza DNA vaccine (HA DNA) and licensed trivalent influenza vaccine (TIV) administered intradermally (ID) or intramuscularly (IM). The hypothesis is that evaluation of these investigational schedules will inform development of novel influenza vaccine strategies that may offer improved and cross-protective immunity against antigenically diverse influenza strains.

Influenza

National Institute of Allergy and Infectious Diseases (NIAID)316 participantsStarted Aug 2012

Stanford, California, United States • Iowa City, Iowa, United States • St Louis, Missouri, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Open-Label Extension and Safety Study of Talazoparib

NCT02921919

This is a single-arm, open-label, extended treatment, safety study in patients treated with talazoparib in qualifying studies.

Cancer

Pfizer120 participantsStarted Nov 2016

Alhambra, California, United States • Bakersfield, California, United States • Burbank, California, United States +35 more locations

Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years

Open-Label Extension and Safety Study of Talazoparib

Find Trials by Condition in Houston

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

3T MRI CIED Post-Approval Study

A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS

Genomic Translation for Amyotrophic Lateral Sclerosis Care

Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Leveraging the Emergency Department to Engage African American Women in HIV Pre-Exposure Prophylaxis

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation

To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS

A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis